BNP Paribas Financial Markets’s Spero Therapeutics SPRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$116 Buy
40
+28
+233% +$81 ﹤0.01% 4504
2025
Q1
$9 Hold
12
﹤0.01% 4506
2024
Q4
$12 Hold
12
﹤0.01% 4505
2024
Q3
$16 Hold
12
﹤0.01% 3380
2024
Q2
$16 Hold
12
﹤0.01% 3335
2024
Q1
$21 Hold
12
﹤0.01% 3327
2023
Q4
$18 Hold
12
﹤0.01% 3263
2023
Q3
$15 Buy
+12
New +$15 ﹤0.01% 3204
2023
Q1
Sell
-668
Closed -$1.16K 3314
2022
Q4
$1.16K Buy
668
+146
+28% +$253 ﹤0.01% 3121
2022
Q3
$1.04K Sell
522
-26,654
-98% -$53.3K ﹤0.01% 3709
2022
Q2
$20.1K Buy
27,176
+24,668
+984% +$18.3K ﹤0.01% 3056
2022
Q1
$21.8K Sell
2,508
-6,489
-72% -$56.5K ﹤0.01% 3139
2021
Q4
$144K Buy
8,997
+4,654
+107% +$74.5K ﹤0.01% 2852
2021
Q3
$80K Buy
4,343
+3,396
+359% +$62.5K ﹤0.01% 2769
2021
Q2
$13.2K Sell
947
-13,382
-93% -$187K ﹤0.01% 3054
2021
Q1
$211K Buy
14,329
+10,535
+278% +$155K ﹤0.01% 2476
2020
Q4
$73.6K Buy
3,794
+473
+14% +$9.17K ﹤0.01% 2719
2020
Q3
$37.1K Buy
3,321
+2,871
+638% +$32K ﹤0.01% 2979
2020
Q2
$6.09K Sell
450
-3,384
-88% -$45.8K ﹤0.01% 3289
2020
Q1
$31K Buy
3,834
+1,042
+37% +$8.42K ﹤0.01% 3151
2019
Q4
$26.8K Buy
2,792
+1,353
+94% +$13K ﹤0.01% 3251
2019
Q3
$15.3K Buy
1,439
+8
+0.6% +$85 ﹤0.01% 3413
2019
Q2
$16.5K Sell
1,431
-276
-16% -$3.18K ﹤0.01% 3338
2019
Q1
$21.9K Buy
1,707
+1,341
+366% +$17.2K ﹤0.01% 3286
2018
Q4
$2.25K Buy
366
+145
+66% +$892 ﹤0.01% 3100
2018
Q3
$2.32K Sell
221
-13
-6% -$137 ﹤0.01% 3571
2018
Q2
$3.43K Sell
234
-827
-78% -$12.1K ﹤0.01% 3533
2018
Q1
$15.1K Sell
1,061
-182
-15% -$2.59K ﹤0.01% 3378
2017
Q4
$14.6K Buy
+1,243
New +$14.6K ﹤0.01% 3323